FlexmiR Select, a new assay designed by Luminex, will allow researchers to improve their analysis of microRNAs (miRNA) – single-stranded RNA molecules which regulate gene expression. FlexmiR Select allows researchers to create […]
[Video] Interview with Joseph Gulfo, President and CEO of Electro-Optical Sciences
We gathered this footage back in September at the Think Equity G5 Growth Conference. In this segment, Gulfo discusses MelaFind – a handheld device that capture images of suspicious pigmented skin lesions. […]
Stock Offering Fuels Inverness’ Thirst for Acquisition
Buoyed by a recent stock offering, the Inverness Medical machine continues to gobble up companies as they consolidate the disease and health management service space. The most recent acquisition of ParadigmHealth will […]
Partnership with GE Healthcare Sends iCAD Shares Soaring
Last week GE Healthcare announced would it would be incorporating iCAD’s SecondLook technology into its line of Senographe Full-Field Digital mammography systems. iCAD shares opened 10% higher on the news; shares have […]
More Good News from Aethlon, Hemopurifier Reverses Immune Suppression in Cancer Patients
Aethlon’s prospects seem to be growing brighter by the minute. Last week I reported that the company had initiated a research collaboration to study the in vitro effectiveness of clearing HIV from […]
AngioDynamics’ RFA Shows Promise for Patients with Unresectable Liver Metastases
A recent study conducted by Dr. Allan Siperstein and colleagues at the Cleveland Clinic presented three and five year survival data following radiofrequency ablation of colorectal liver metastases. As Siperstein noted in […]
Minneapolis Firm Raises $11.8M for Lymphedema System
Tactile Systems Technology, a Minneapolis, MN, company whose technology treats vascular disorders such as lymphedema, has raised $11.8 million. The financing, led by Galen Partners of Stamford, CT, will be used to […]
New Cervical-Cancer Test Cleared in Europe
Diamics, a Novato, CA, diagnostics company, has received CE Mark approval for a molecular-based cervical cancer-screening tool designed to improve the effectiveness of traditional testing methods. The Pap-Map System — which uses […]
